Annual Report 2005 of Square Pharmaceuticals Limited

It is a broadly described annual report of Square Pharmaceuticals Limited in the year of 2004-2005. The company contributed an amount of Taka. 1,233,438,339 (including Taka. 14,571,174 as contribution towards machinery & spare parts imports) to National Exchequer as against Taka. 1,102,617,542 in the previous year indicating an increase of 11.86%. During the financial year, The Company’s Gross Turnover Tk. 6,199,134,802. Cost of Goods Sold Tk. 3,159,453,706. Gross Profit Tk. 2,172,592,929. Profit before Tax Tk. 1,513,018,599. Net Profit after Tax for the year Tk. 1,255,848,153. The Earning per Share of Tk. 290.71 is based on increased outstanding 4,320,000 shares of Tk. 100 each. However, if the original issued capital for cash at the time of IPO is considered, the EPS would stand at Tk. 627.92 in 2004-2005 as against Tk. 485.02 in 2003-2004.

The Board also recommended for the declaration of Bonus Shares (Stock Dividend) @15%. This will need issuance of 648,000 ordinary shares of Tk. 100 each with an appropriation of Tk. 64,800,000 to Capital Account. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Square Pharmaceuticals Limited: